Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.4450
+0.0110 (2.53%)
At close: Aug 13, 2025, 4:00 PM
0.4401
-0.0049 (-1.10%)
Pre-market: Aug 14, 2025, 9:03 AM EDT
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $34.94 million as of August 14, 2025. Its market cap has decreased by -60.03% in one year.
Market Cap
34.94M
Enterprise Value
81.80M
1-Year Change
-60.03%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from $142.00M to $34.94M, a decrease of -75.40%. That is a compound annual growth rate of -14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 34.90M | -51.60% |
| Dec 31, 2024 | 72.10M | -1.23% |
| Dec 29, 2023 | 73.00M | 8.31% |
| Dec 30, 2022 | 67.40M | -58.93% |
| Dec 31, 2021 | 164.10M | 23.85% |
| Dec 31, 2020 | 132.50M | 11.06% |
| Dec 31, 2019 | 119.30M | 247.81% |
| Dec 31, 2018 | 34.30M | -80.67% |
| Dec 29, 2017 | 177.40M | -3.53% |
| Dec 30, 2016 | 183.90M | 29.51% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |